ANUHPHRNSEAnuh Pharma Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 19 Jun, 2026 · 17:53 IST

Anuh Pharma faces Income Tax penalty of about Rs 17.46 lakh for AY 2020-21

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.6%Reaction day
₹77.65
prior close
₹78.80
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+0.8% vs market
Pharmaceuticals peers, median of 162sector+0.4%+1.2% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
+0.8
15m
+0.0
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.6+0.8+0.8+0.4+1.2
Next day
+1.7+0.1+1.6+1.4+0.3
2d
+2.0+0.0+2.0+1.0+1.0
3d
+0.7-0.6+1.3+0.8-0.1
4d
+3.2-0.9+4.0+0.9+2.2
5d
+4.3+0.2+4.2+2.6+1.7
1w
+4.7+1.2+3.5+2.3+2.4
15d
+3.0+0.7+2.3+4.3-1.3
1m
+3.7-0.4+4.1+2.3+1.4
2m
-0.2+5.2-5.4+2.9-3.1
3m
+20.4+5.4+15.0+7.1+13.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Income Tax Department issued a Demand Order under Section 156 and Penalty Order under Section 270A against Anuh Pharma for Assessment Year 2020-21. The action relates to disallowance of certain deductions. Total financial impact is about Rs 17,46,026 including penalty. The company plans to appeal before higher appellate forums and believes it has adequate grounds. Management states there is no material impact on operations.

Likely market impact

Small financial impact of about Rs 17.46 lakh. Company plans to appeal. No material impact on operations stated by management.